Registration
View rates and + register for Advancing Gene + Cell Therapies for Cancer!
Register Today
Event Description
As of mid-2024, six engineered cell therapy products are commercially available for hematologic malignancies, with one non-engineered adoptively transferred cell product approved for melanoma treatment. The past decade of academic and commercial development has delivered exciting scientific and remarkable clinical advances, and the future promises a myriad of opportunities for further advancements.
During this conference, experts in the field will share their insights on targeting cancer-specific antigens, highlight rational combinations to further enhance the function of CAR engineered cells, describe ground-breaking efforts to engineer CAR engineered cells directly in vivo, and illuminate the biology and risks of viral vector integration.
You’ll delve into the latest advancements in the field alongside the innovators who are shaping the future of cancer research in an intimate environment designed to foster learning, collaboration, and meaningful connections.
|
|
Advanced
Ends Sept. 17
|
Regular
Sept. 18-Oct. 15
|
On-site
Oct. 16-17
|
Virtual
Only
|
|
Member
|
$525
|
$600
|
$650
|
$500
|
|
Associate
Member
|
$275
|
$350
|
$400
|
$250
|
Not an ASGCT member? Join before registering for access to these incredible discounts and so much more!
Join Today!
Non-Member Rates
|
|
Advanced
Ends Sept. 17
|
Regular
Sept. 18-Oct. 15
|
On-site
Oct. 16-17
|
Virtual
Only
|
|
Non-Member
|
$725
|
$800
|
$850
|
$700
|
|
US Federal
Government
|
$575
|
$650
|
$700
|
$550
|
|
Graduate Students &
Post-Doctoral Fellows
|
$375
|
$450
|
$500
|
$350
|
If you are a member of the media, please email media@asgct.org to learn about complimentary press registration.
Abstract Authors
ASGCT members can save up to $200 on registration, and Associate Members (students and postdoctoral fellows) who are first and presenting authors can get a discounted* registration rate of $175! Be sure to register to attend in-person or virtually, or submit an abstract to be considered for an oral or poster presentation.
*Discounted rates do not apply if your abstract is withdrawn or rejected.
Registration Benefits
Advancing Gene and Cell Therapies for Cancer is a hybrid event. In-person and virtual registrations are available for this program.
Cancellations and Transfers
There is a $75 cancellation fee, and the balance will be refunded for cancellation requests received by September 16, 2024. There will be no refunds for cancellation requests received after September 16, 2024 at 11:59 p.m. ET. If you are unable to attend, you may transfer the badge (one time) to another person within the same company/institution before October 9, 2024.
If you must change from in-person registration to virtual registration, you may do so one time only for a 50% refund of the price difference up until September 16, 2024. Any change to registration type after this date will not be refunded.
Changes from virtual registration to in-person registration may be done any time at the prevailing in-person registration rates.
Payments must be received by close of the prevailing registration rate period otherwise the registration rate will be updated to the next rate period.
Please note checks and wire transfers are not accepted forms of payment for this event.
Please contact meetings@asgct.org to make any of the above changes to your registration.
Ready to Register?
Register today!